Subcutaneous Implantable Cardioverter-Defibrillator Implantation Without Defibrillation Testing.

Marc A Miller,Chandrasekar Palaniswamy,Srinivas R Dukkipati, Sujata Balulad,Jeffrey Smietana, Aaron Vigdor,Jacob S Koruth,Subbarao Choudry,William Whang,Vivek Y Reddy

Journal of the American College of Cardiology（2017）

引用 21|浏览10

暂无评分

摘要

Defibrillation testing (DT) does not improve shock efficacy or reduce the risk for arrhythmic death in patients undergoing routine transvenous implantable cardioverter-defibrillator (ICD) placement and is no longer compulsory for left pectoral transvenous ICDs [(1)][1]. The subcutaneous ICD (S-ICD)

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要